Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors
Flora Pirozzi, Remo Poto, Luisa Aran, Alessandra Cuomo, Maria Rosaria Galdiero, Giuseppe Spadaro, Pasquale Abete, Domenico Bonaduce, Gianni Marone, Carlo G. Tocchetti, Gilda Varricchi, Valentina Mercurio
Topics & Concepts
MedicineAdverse effectImmune systemMyocarditisNivolumabImmunologyAutoimmunityPericarditisVasculitisImmunotherapyInternal medicineDiseaseCancer Immunotherapy and BiomarkersChemotherapy-induced cardiotoxicity and mitigationPeptidase Inhibition and Analysis